Schrodinger Inc (SDGR) Return on Equity ROE from the second quarter 2026 to second quarter 2025 and annually, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Schrodinger Inc   (NASDAQ: SDGR)

Schrodinger Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Schrodinger Inc in the second quarter 2026?
Schrodinger Inc recorded a cumulative net loss of $-54 million during 12 months ending in the second quarter 2026, resulting in a negative return on equity (ROE) of -16.37%.

Within the Major Pharmaceutical Preparations industry 89 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2026 from 2981 to 3020.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Equity Change -4.06 % -16.05 % -13.62 % -28.5 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -54 -103 -103 -176 -181
Return On Equity (TTM) -16.37 % -30.85 % -29.47 % -48.24 % -45.7 %
SDGR's Total Ranking # 3020 # 2981 # 2653 # 2660 #
Equity (TTM) in Millions 329 314 364 321 343
Seq. Equity Change 4.91 % -13.87 % 13.29 % -6.28 % -8.2 %
Seq. Net Income Change - - - - -

Back to SDGR Management Effectiveness >> SDGR's 5 Years Annual ROE >> Compare SDGR ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 90
Sector # 263
Overall # 3020

Return On Equity Statistics
High Average Low
12.56 %
-19.38 %
-48.24 %
(Jun 30 2023)   (Sep 30 2025)



  News about Schrodinger Inc Return on Equity ROE

Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrodinger Expands Its Talent Pool with Strategic RSU Grants Under Nasdaq Listing RuleIn a notable move to bolster its workforce and align with industry standards for employee compensation, Schrodinger, Inc. (Nasdaq: SDGR) has disclosed the granting of restricted stock units (RSUs) to four newly hired employees. This announcement, made on November 14, 2024, expands upon Schrodinger s commitment to leveraging its 2021 Inducement Equity Incentive Plan, which serves as a driving force behind attracting and retaining top-tier talent within the highly competitive biopharmaceutical sector.The decision to grant these RSUs, amounting to 2,785 shares of the company’s common stock, was conducted with due diligence by the company’s compensation committee. This committee operates under the auspices of the board of directors, who have authorized the delegation of such responsibilities to ensure that strategic HR decisions align with the broader goals of the organization. By employing this structure, Schrodinger not only adheres to stringent Nasdaq Listing Rule 5635(c)(4) requirements but also showcases its dedication to providing meaningful incentives that promote employee engagement and longevity.



SDGR Annual Return On Equity (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Equity in Millions 364 421 549 448 557
Y / Y Equity Change -13.62 % -23.17 % 22.47 % -19.6 % -10.73 %
Net Income in Millions -103 -187 41 -149 -101
Y / Y Net Income Change - - - - -
Return On Equity -28.37 % -44.4 % 7.42 % -33.31 % -18.17 %

Back to SDGR Management Effectiveness >> SDGR's 5 Years Annual ROE >> Compare SDGR ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
SDGR's' Return on Equity at Yahoo Finance
SDGR's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for SDGR's Competitors
Subscribers only: Roe for Schrodinger Inc 's Suppliers
Subscribers only: Return On Equity for SDGR's Customers




Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector ROE

Date modified: 2026-09-09T00:12:03+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.